0001144204-16-081239
venBio Select Advisor LLC (CIK 0001633313)
Total Value: $290,298
Total Holdings: 31
| Quarter | Filling ID |
|---|---|
| Q4 25 | 0002002654-26-000001 |
| Q3 25 | 0002002654-25-000006 |
| Q2 25 | 0002002654-25-000004 |
| Q1 25 | 0002002654-25-000003 |
| Q4 24 | 0002002654-25-000001 |
| Q3 24 | 0002002654-24-000005 |
| Q2 24 | 0002002654-24-000004 |
| Q1 24 | 0002002654-24-000002 |
| Q4 23 | 0002002654-24-000001 |
| Q3 23 | 0002002654-23-000008 |
| Q2 23 | 0002002654-23-000007 |
| Q1 23 | 0002002654-23-000006 |
| Q4 22 | 0002002654-23-000005 |
| Q3 22 | 0002002654-23-000004 |
| Q2 22 | 0002002654-23-000003 |
| Q1 22 | 0002002654-23-000002 |
| Q4 21 | 0002002654-23-000001 |
| Name | Title | CUSIP | Ticker | Value | Shares | Share Price | Investment | % of Portfolio |
|---|---|---|---|---|---|---|---|---|
| MIRATI THERAPEUTICS INC. | Common | 60468T105 | MRTXEUR | $39,755 | 1,258,055 | SOLE | ||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | FOLD | $34,101 | 3,515,611 | SOLE | ||
| LION BIOTECHNOLOGIES INC | Common | 53619R102 | $24,608 | 3,187,607 | SOLE | |||
| LA JOLLA PHARMACEUTICAL CO. | Common | 503459604 | LJPC | $21,173 | 784,199 | SOLE | ||
| SAREPTA THERAPEUTICS -INC | Common | 803607100 | SRPT | $20,032 | 550,307 | SOLE | ||
| PERNIX THERAPEUTICS HOLDINGS | Common | 71426V108 | $15,178 | 5,144,916 | SOLE | |||
| DERMIRA INC | Common | 24983L104 | DERMEUR | $12,285 | 354,950 | SOLE | ||
| TELIGENT INC. | Common | 87960W104 | $12,222 | 1,373,294 | SOLE | |||
| VANDA PHARMACEUTICALS INC | Common | 921659108 | VNDA | $11,738 | 1,260,809 | SOLE | ||
| SORRENTO THERAPEUTICS INC | Common | 83587F202 | SRNE | $9,987 | 1,146,579 | SOLE | ||
| AGENUS – INC | Common | 00847G705 | AGENEUR | $9,984 | 2,199,137 | SOLE | ||
| ONCOTHYREON INC | Common | 682324108 | $9,144 | 4,119,072 | SOLE | |||
| NEURODERM LTD. | Common | M74231107 | $8,866 | 520,022 | SOLE | |||
| NANTKWEST- INC | Common | 63016Q102 | NK1USD | $8,828 | 599,287 | SOLE | ||
| AEGERION PHARMACEUTICALS INC | Common | 00767E102 | $7,405 | 733,125 | SOLE | |||
| NEUROCRINE BIOSCIENCES INC | Common | 64125C109 | $7,184 | 127,000 | SOLE | |||
| AXOVANT SCIENCES LTD. | Common | G0750W104 | $5,536 | 307,070 | SOLE | |||
| VERACYTE INC | Common | 92337F107 | VCYT | $5,338 | 741,353 | SOLE | ||
| EGALET CORPORATION. | Common | 28226B104 | EGLTEUR | $4,767 | 432,606 | SOLE | ||
| INNOCOLL AG | Sponsored ADR | 45780Q103 | $4,164 | 501,722 | SOLE | |||
| FORTRESS BIOTECH INC. | Common | 34960Q109 | $3,733 | 1,337,869 | SOLE | |||
| TRILLIUM THERAPEUTICS INC | Common | 89620X506 | TREUR | $3,199 | 253,697 | SOLE | ||
| VERICEL CORP. | Common | 92346J108 | VCEL | $2,929 | 1,135,120 | SOLE | ||
| TONIX PHARMACEUTICALS HLDG | Common | 890260201 | $2,610 | 340,300 | SOLE | |||
| ACCELERATE DIAGNOSTICS, INC. | Common | 00430H102 | $2,426 | 112,885 | SOLE | |||
| ALLIQUA BIOMEDICAL INC | Common | 019621200 | $1,796 | 839,100 | SOLE | |||
| CELLECTIS – ADR | Sponsored ADS | 15117K103 | CLLS | $1,086 | 35,000 | SOLE | ||
| CATALYST BIOSCIENCES INC. | Common | 14888D109 | $224 | 71,500 | SOLE |